|
|
SYNAPTIC PLD1 LEVELS/SIGNALING IS ELEVATED THROUGH EPIGENETIC REGULATION IN THE CNS OF AD PATIENTS AS A FUNCTION OF DISEASE SEVERITY AND COGNITIVE DECLINE |
| 5R21AG059223-02 |
KRISHNAN, BALAJI |
NIA |
2019 |
|
|
NEUROMUSCULAR AND BIOMECHANICAL CONTROL OF LOWER LIMB LOADING IN INDIVIDUALS WITH CHRONIC STROKE |
| 5R21AG060034-02 |
GRAY, VICKI L. |
NIA |
2019 |
|
|
DEVELOPMENT OF SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RAGE AS A TREATMENT FOR ALZHEIMER'S DISEASE |
| 5R21AG060208-02 |
LYKENS, NICOLE M |
NIA |
2019 |
|
|
NEUROMETABOLIC PROFILE OF MILD COGNITIVE IMPAIRMENT USING MULTIPLEXED EDITED MRS |
| 5R21AG060245-02 |
EDDEN, RICHARD ANTHONY EDWARD |
NIA |
2019 |
|
|
IMPACT OF AGING AND INFLUENZA INFECTION ON MUSCLE HEALTH |
| 5R21AG060389-02 |
HAYNES, LAURA |
NIA |
2019 |
|
|
THE DISABLEMENT PROCESS OF AGING UNITED STATES VETERANS |
| 5R36AG060214-02 |
URENA, STEPHANIE |
NIA |
2019 |
|
|
A THERAPEUTIC WEARABLE SENSOR FOR DYSPHAGIA |
| 5R41AG062023-02 |
XU, SHUAI |
NIA |
2019 |
|
|
ASTROCYTE ACTIVATION BY SMALL-MOLECULE ADORA3 AGONISTS: A NOVEL THERAPY FOR ALZHEIMER'S DISEASE |
| 5R41AG062163-02 |
LECHLEITER, JAMES D |
NIA |
2019 |
|
|
IDENTIFYING NEW IMMUNOMODULATORY TARGETS FOR ALZHEIMERS AND OTHER NEURODEGENERATIVE DISEASES |
| 5R43AG060787-02 |
DORANZ, BENJAMIN JACOB |
NIA |
2019 |
|
|
DEVELOPMENT AND EVALUATION OF COMPUTERIZED OLFACTORY TRAINING PROGRAM (COT) FOR COGNITIVE DECLINE IN PRECLINICAL AND EARLY ALZHEIMER'S DISEASE (AD) |
| 5R43AG061981-02 |
SETH, SUMEET |
NIA |
2019 |
